FDA Inspection 1023331 — Orchid Pharma Limited
The FDA completed an inspection of Orchid Pharma Limited on June 14, 2017 in Chennai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chennai (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)